AU2022900642A0 - Compositions and methods for treating neurological disorders with combination products - Google Patents

Compositions and methods for treating neurological disorders with combination products

Info

Publication number
AU2022900642A0
AU2022900642A0 AU2022900642A AU2022900642A AU2022900642A0 AU 2022900642 A0 AU2022900642 A0 AU 2022900642A0 AU 2022900642 A AU2022900642 A AU 2022900642A AU 2022900642 A AU2022900642 A AU 2022900642A AU 2022900642 A0 AU2022900642 A0 AU 2022900642A0
Authority
AU
Australia
Prior art keywords
compositions
methods
neurological disorders
combination products
treating neurological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022900642A
Inventor
unknown unknown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurotech International Ltd
Original Assignee
Neurotech International Ltd
Filing date
Publication date
Application filed by Neurotech International Ltd filed Critical Neurotech International Ltd
Publication of AU2022900642A0 publication Critical patent/AU2022900642A0/en
Priority to PCT/AU2022/051221 priority Critical patent/WO2023060302A1/en
Priority to KR1020247013541A priority patent/KR20240090226A/en
Priority to CA3231512A priority patent/CA3231512A1/en
Priority to JP2024518641A priority patent/JP2024537734A/en
Priority to EP22879680.1A priority patent/EP4415739A1/en
Priority to IL311854A priority patent/IL311854A/en
Priority to AU2022367003A priority patent/AU2022367003A1/en
Pending legal-status Critical Current

Links

AU2022900642A 2021-10-11 2022-03-16 Compositions and methods for treating neurological disorders with combination products Pending AU2022900642A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PCT/AU2022/051221 WO2023060302A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders with combination products
KR1020247013541A KR20240090226A (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders using combination products
CA3231512A CA3231512A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders with combination products
JP2024518641A JP2024537734A (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders with combination products - Patents.com
EP22879680.1A EP4415739A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders with combination products
IL311854A IL311854A (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders with combination products
AU2022367003A AU2022367003A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders with combination products

Publications (1)

Publication Number Publication Date
AU2022900642A0 true AU2022900642A0 (en) 2022-03-31

Family

ID=

Similar Documents

Publication Publication Date Title
IL311854A (en) Compositions and methods for treating neurological disorders with combination products
EP4076422A4 (en) Methods for improving neurological diseases and disorders
EP3917620A4 (en) Compositions and methods for treating neurocognitive disorders
EP3917539A4 (en) Compositions and methods for treating neurocognitive disorders
EP4096439A4 (en) Compositions and methods for treating aging-related disorders
EP3979985A4 (en) Compositions and methods for treating central nervous system disorders
EP4210755A4 (en) Compositions and methods for the treatment of neurological disorders
EP3917622A4 (en) Compositions and methods for treating anxiety-related disorders
EP4188368A4 (en) Compositions and methods for treating diseases and disorders
EP3917623A4 (en) Compositions and methods for treating neurocognitive disorders
EP3979996A4 (en) Methods and formulations for treating vision disorders
EP4208159A4 (en) Compositions and methods for improving neurological diseases and disorders
EP4045084A4 (en) Compositions and methods for treating blood disorders
EP4090736A4 (en) Compositions and methods for treating, ameliorating, and/or preventing diseases or disorders caused by or associated with dnase1 and/or dnase1l3 deficiency
IL311852A (en) Compositions and methods for treating neurological disorders
AU2022901714A0 (en) Compositions and methods for treating neurological disorders with combination products
AU2022900642A0 (en) Compositions and methods for treating neurological disorders with combination products
EP3735129A4 (en) Compositions and methods for treating neurological and other disorders
AU2021903259A0 (en) Compositions and methods for treating neurological disorders with combination products
EP4136103A4 (en) Compositions and methods for treating neuropsychiatric disorders
EP4103177A4 (en) Compositions and methods for treating and/or preventing ocular disorders
EP4076429A4 (en) Compositions and methods for treating neuromuscular disorders
EP4219450A4 (en) 6-methoxy-2-phenethyl isoindoline-1-one derivative and composition for treating neurological disorders, comprising same
AU2022901710A0 (en) Compositions and methods for treating neurological disorders
AU2022900640A0 (en) Compositions and methods for treating neurological disorders